|
Market Closed -
Nasdaq Tallinn
17:30:00 14/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 17.50 EUR | +0.57% |
|
-2.78% | -37.50% |
| 1 day | +0.57% | ||
| 1 week | -2.78% | ||
| Current month | -7.41% | ||
| 1 month | -8.85% | ||
| 3 months | -21.17% | ||
| 6 months | -23.91% | ||
| Current year | -37.50% |
| 1 week | 17 |  | 18 |
| 1 month | 10.2 | | 19.2 |
| Current year | 10.2 | | 28 |
| 1 year | 10.2 | | 30.8 |
| 3 years | 9.8 | | 32.6 |
| 5 years | 5 | | 32.6 |
| 10 years | 5 | | 32.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | 52 | 01/01/2015 | |
Liina Kervemann
DFI | Director of Finance/CFO | - | - |
Erik Berlin
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Karita Sall
BRD | Director/Board Member | 52 | - |
Yoann John Ricau
BRD | Director/Board Member | 51 | - |
Martin Wilson
BRD | Director/Board Member | 49 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | -2.78% | -32.69% | +69.08% | 34.05M | |
| -1.13% | -3.11% | +13.82% | +60.17% | 46.21B | |
| -0.62% | -6.36% | +32.44% | +108.15% | 38.78B | |
| +0.12% | -0.08% | +7.12% | +73.98% | 11.68B | |
| -0.53% | -1.37% | -13.25% | +11.19% | 11.55B | |
| +0.96% | -1.32% | +19.32% | +145.33% | 9.14B | |
| +0.24% | -2.03% | +23.38% | +35.93% | 7.3B | |
| +0.17% | -0.74% | +13.44% | +180.68% | 7.15B | |
| +0.75% | -4.53% | +35.35% | -18.67% | 7.1B | |
| +0.60% | -3.72% | -44.55% | +13.55% | 4.97B | |
| Average | +0.11% | -2.31% | +5.44% | +67.94% | 14.39B | |
| Weighted average by Cap. | -0.42% | -3.11% | +15.97% | +74.95% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | €17.50 | +0.57% | 18 |
| 10/09/26 | €17.40 | -0.57% | 22 |
| 09/09/26 | €17.50 | -2.78% | 121 |
| 08/09/26 | €18.00 | 0.00% | 8 |
- Stock Market
- Stocks
- MOLNRIPO Stock
Select your edition
All financial news and data tailored to specific country editions
